• Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]
• Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624); Part D Beneficiary Appeals Fairness Act (S. 1488)]

Duration: October 1, 2012 to December 31, 2015

General Issues: Health Issues, Medicare/Medicaid

Spending: about $590,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2012: U.S. Senate, House of Representatives, Executive Office of the President (EOP)